NCT02273323View on ClinicalTrials.gov

Flow Mediated Dilation in Response to Black Tea

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Vascular Function
Interventions
OTHER

Tea

Single dose of black tea infusion containing approximately 400 mg flavonoids (expressed as gallic acid equivalents) with added sugar.

OTHER

Placebo

Placebo: tea flavour, colouring and sugar

Trial Locations (1)

SE1 7EH

Dept Clinical Pharmacology/CRF, St Thomas Hospital, London

All Listed Sponsors
collaborator

King's College London

OTHER

lead

Unilever R&D

INDUSTRY

NCT02273323 - Flow Mediated Dilation in Response to Black Tea | Biotech Hunter | Biotech Hunter